CompletedNCT00557960
Adderall XR or atomoxetine for ADHD and driving skills in adults
About this title
Read the official source —Medication studyAges 19–25United States
Understand this study
Who was this study for?
Listed age limits: 19 years to 25 years.
- Listed locations
- Washington D.C.See all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: February 25, 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 36
- Sponsor
- Shire
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 19 Years to 25 Years
- Official registry ID
- NCT00557960
- Official title
Show the full official title
A Phase IIIb Study to Evaluate the Efficacy and Time Course of Treatment With ADDERALL XR and STRATTERA Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Get this study by email
Recruitment & locations
CompletedWashington D.C.
Questions about this study
Who is behind this study?
The study sponsor is Shire.
Did this study involve medication?
Yes. The study involved medication, including Mixed salts of a single-entity amphetamine and Atomoxetine hydrochloride.
Who was this study for?
Listed age limits: 19 years to 25 years.
